Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 9,421 - 9,440 results of 51,875 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 0.62s Refine Results
  1. 9421

    mGluR5 binding potential (BP<sub>ND</sub>) decreased in epilepsy models according to time periods after status epilepticus. by Hongyoon Choi (541919)

    Published 2014
    “…<p>(A–C) BP<sub>ND</sub> decreased globally in acute period after status epilepticus. …”
  2. 9422
  3. 9423

    Preserved NSS at 2 and at 24 hours following ischemia and decreased infarct volume in PAR1 KO mice 24 hours following ischemic stroke. by Efrat Shavit-Stein (3186678)

    Published 2021
    “…(C) Total infarct volume is significantly lower in PAR1 KO mice compared to control (t-test, WT = 6, PAR1 KO = 6). (D) Infarct volume decreases as a function of distance from the ischemic core (slices #5&6). …”
  4. 9424

    VEGFq treatment decreases newly transcribed <i>VEGF</i> mRNA and protein expression and downstream ERK1/2 and AKT mediated signaling. by David Muench (1343364)

    Published 2019
    “…Note a 40% decrease in newly synthesized <i>VEGF</i> mRNA and a profound decrease in protein expression. …”
  5. 9425
  6. 9426

    The penetration of OU14 but not RACE1 decreased in epidermal cells in which <i>MLO</i> expression was suppressed by transient induced gene silencing (TIGS). by Takashi Yaeno (11320498)

    Published 2021
    “…The empty pANDA-mini vector was introduced as a negative control. The mean values of these experiments were calculated from independent experimental data obtained from 2–10 introduced leaves. *, <i>P</i> < 0.05; **, <i>P</i> < 0.01 (Student’s <i>t</i>-test).…”
  7. 9427
  8. 9428
  9. 9429
  10. 9430
  11. 9431

    Decreased AMPKα expression in <i>NGLY1</i> deficiency patient fibroblasts and rescue of impaired cellular respiration in these cells by PT1 treatment. by Seung Yeop Han (9767739)

    Published 2020
    “…<p>(A) qRT-PCR assays show a significant decrease in the mRNA levels of <i>AMPKα1</i> and <i>AMPKα2</i> in two different <i>NGLY1</i> deficiency patient fibroblasts compared to control (<i>NGLY1</i><sup><i>+/+</i></sup>) and two different parents (<i>NGLY1</i><sup><i>+/–</i></sup>) fibroblasts. …”
  12. 9432

    Inhibition of miR-181c and miR-130b decreased cell viability and invasion in Y79 and WERI-Rb-1 cells. by Madhu Beta (674091)

    Published 2014
    “…<p>A) Percentage of cell viability changes in anti-miR181c and anti-miR130b transfected Y79 and WERI-Rb-1 cells. …”
  13. 9433
  14. 9434
  15. 9435
  16. 9436
  17. 9437
  18. 9438

    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

    Published 2025
    “…<p><b>(A)</b> A significant reduction in colony-forming ability was observed in U87MG cells treated with 100ΜM SHG-44 compared to 100ΜM cis-platin and the untreated control. …”
  19. 9439

    A H<sub>2</sub>S-Nampt Dependent Energetic Circuit Is Critical to Survival and Cytoprotection from Damage in Cancer Cells by Reiko Sanokawa-Akakura (254909)

    Published 2014
    “…Together, these data show that upon recovery from potential lethal damage, H<sub>2</sub>S-Nampt directs energy expenditure and aerobic glycolysis in cancer cells, leads to their exponential growth, and causes a high degree of tolerance to damage. Identification of H<sub>2</sub>S-Nampt as a pathway responsible for induction of damage tolerance in cancer cells may underlie resistance to therapy and offers the opportunity to target this pathway as a means in treatment of cancer.…”
  20. 9440